EP3441466 - METHOD FOR PRODUCING A NOVEL RECOMBINANT FACTOR C, METHOD FOR MITIGATING REACTION INHIBITION IN ENDOTOXIN ASSAYS, AND METHOD FOR MEASURING ENDOTOXIN [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 03.01.2020 Database last updated on 24.08.2024 | |
Former | Grant of patent is intended Status updated on 12.08.2019 | ||
Former | Examination is in progress Status updated on 12.03.2019 | ||
Former | Request for examination was made Status updated on 22.02.2019 | ||
Former | The application has been published Status updated on 11.01.2019 | Most recent event Tooltip | 10.07.2024 | New entry: Decision (+date) in appeal procedure | 10.07.2024 | Deletion: Date of oral proceedings | Applicant(s) | For all designated states Seikagaku Corporation 6-1, Marunouchi 1-chome Chiyoda-ku Tokyo 100-0005 / JP | [2019/07] | Inventor(s) | 01 /
MIZUMURA, Hikaru c/o SEIKAGAKU CORPORATION Central Research Laboratories, 1253, Tateno 3-chome Higashiyamoto-shi Tokyo, 207-0021 / JP | 02 /
ODA, Toshio c/o SEIKAGAKU CORPORATION Central Research Laboratories, 1253, Tateno 3-chome Higashiyamoto-shi Tokyo, 207-0021 / JP | 03 /
KAWABATA, Shun-ichiro c/o KYUSHU UNIVERSITY 6-10-1 Hakozaki, Higashi-ku, Fukuoka-shi Fukuoka, 812-8581 / JP | [2019/07] | Representative(s) | Müller-Boré & Partner Patentanwälte PartG mbB Friedenheimer Brücke 21 80639 München / DE | [2019/07] | Application number, filing date | 18190686.8 | 10.12.2013 | [2019/07] | Priority number, date | JP20120269840 | 10.12.2012 Original published format: JP 2012269840 | [2019/07] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3441466 | Date: | 13.02.2019 | Language: | EN | [2019/07] | Type: | B1 Patent specification | No.: | EP3441466 | Date: | 05.02.2020 | Language: | EN | [2020/06] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 10.01.2019 | Classification | IPC: | C12N15/09, C12N9/64, C12P21/02, C12Q1/37, G01N33/569, G01N33/579 | [2019/07] | CPC: |
C12N9/6408 (EP,US);
C12Y304/21069 (EP,US);
C12Y304/21084 (EP,US);
G01N33/56911 (EP,US);
G01N33/579 (EP,US);
G01N2333/96411 (US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/13] |
Former [2019/07] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | VERFAHREN ZUR HERSTELLUNG EINES NEUARTIGEN REKOMBINANTEN FAKTORS C, VERFAHREN ZUR VERMINDERUNG DER REAKTIONSHEMMUNG IN ENDOTOXIN-ASSAYS UND VERFAHREN ZUR MESSUNG VON ENDOTOXIN | [2019/07] | English: | METHOD FOR PRODUCING A NOVEL RECOMBINANT FACTOR C, METHOD FOR MITIGATING REACTION INHIBITION IN ENDOTOXIN ASSAYS, AND METHOD FOR MEASURING ENDOTOXIN | [2019/07] | French: | PROCÉDÉ DE PRODUCTION D'UN NOUVEAU FACTEUR C DE RECOMBINAISON, PROCÉDÉ PERMETTANT D'ATTÉNUER L'INHIBITION DE RÉACTION DANS DES DOSAGES D'ENDOTOXINE ET PROCÉDÉ DE MESURE D'ENDOTOXINE | [2019/07] | Examination procedure | 07.02.2019 | Amendment by applicant (claims and/or description) | 14.02.2019 | Examination requested [2019/13] | 14.02.2019 | Date on which the examining division has become responsible | 15.03.2019 | Despatch of a communication from the examining division (Time limit: M04) | 08.05.2019 | Reply to a communication from the examining division | 13.08.2019 | Communication of intention to grant the patent | 02.12.2019 | Receipt of the translation of the claim(s) | 05.12.2019 | Fee for grant paid | 05.12.2019 | Fee for publishing/printing paid | Parent application(s) Tooltip | EP13862466.3 / EP2930241 | Divisional application(s) | EP19216609.8 / EP3663400 | EP22215393.4 / EP4219705 | Opposition(s) | Opponent(s) | 01
05.11.2020
09.11.2020
ADMISSIBLE Pohlman, Sandra M. df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB Fünf Höfe Theatinerstraße 16 80333 München / DE Opponent's representative Pohlman, Sandra M. df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB Theatinerstrasse 16 80333 München / DE | [2020/51] | 19.11.2020 | Invitation to proprietor to file observations on the notice of opposition | 18.03.2021 | Reply of patent proprietor to notice(s) of opposition | 04.10.2022 | Date of oral proceedings | 26.10.2022 | Despatch of minutes of oral proceedings | 26.10.2022 | Despatch of communication that the patent will be revoked | Appeal following opposition | 22.12.2022 | Appeal received No. T0012/23 | 22.12.2022 | Payment of appeal fee | 24.02.2023 | Statement of grounds filed | 10.07.2024 | Result of appeal procedure: appeal of the proprietor withdrawn | Fees paid | Renewal fee | 30.08.2018 | Renewal fee patent year 03 | 30.08.2018 | Renewal fee patent year 04 | 30.08.2018 | Renewal fee patent year 05 | 17.12.2018 | Renewal fee patent year 06 | 18.12.2019 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 10.12.2013 | AL | 05.02.2020 | AT | 05.02.2020 | CY | 05.02.2020 | CZ | 05.02.2020 | DK | 05.02.2020 | EE | 05.02.2020 | FI | 05.02.2020 | HR | 05.02.2020 | LT | 05.02.2020 | LV | 05.02.2020 | MC | 05.02.2020 | MK | 05.02.2020 | MT | 05.02.2020 | NL | 05.02.2020 | PL | 05.02.2020 | RO | 05.02.2020 | RS | 05.02.2020 | SE | 05.02.2020 | SI | 05.02.2020 | SK | 05.02.2020 | SM | 05.02.2020 | TR | 05.02.2020 | BG | 05.05.2020 | NO | 05.05.2020 | GR | 06.05.2020 | IS | 05.06.2020 | PT | 28.06.2020 | LU | 10.12.2020 | [2022/31] |
Former [2022/30] | HU | 10.12.2013 | |
AL | 05.02.2020 | ||
AT | 05.02.2020 | ||
CY | 05.02.2020 | ||
CZ | 05.02.2020 | ||
DK | 05.02.2020 | ||
EE | 05.02.2020 | ||
FI | 05.02.2020 | ||
HR | 05.02.2020 | ||
LT | 05.02.2020 | ||
LV | 05.02.2020 | ||
MC | 05.02.2020 | ||
MT | 05.02.2020 | ||
NL | 05.02.2020 | ||
PL | 05.02.2020 | ||
RO | 05.02.2020 | ||
RS | 05.02.2020 | ||
SE | 05.02.2020 | ||
SI | 05.02.2020 | ||
SK | 05.02.2020 | ||
SM | 05.02.2020 | ||
TR | 05.02.2020 | ||
BG | 05.05.2020 | ||
NO | 05.05.2020 | ||
GR | 06.05.2020 | ||
IS | 05.06.2020 | ||
PT | 28.06.2020 | ||
LU | 10.12.2020 | ||
Former [2022/27] | HU | 10.12.2013 | |
AT | 05.02.2020 | ||
CY | 05.02.2020 | ||
CZ | 05.02.2020 | ||
DK | 05.02.2020 | ||
EE | 05.02.2020 | ||
FI | 05.02.2020 | ||
HR | 05.02.2020 | ||
LT | 05.02.2020 | ||
LV | 05.02.2020 | ||
MC | 05.02.2020 | ||
MT | 05.02.2020 | ||
NL | 05.02.2020 | ||
PL | 05.02.2020 | ||
RO | 05.02.2020 | ||
RS | 05.02.2020 | ||
SE | 05.02.2020 | ||
SI | 05.02.2020 | ||
SK | 05.02.2020 | ||
SM | 05.02.2020 | ||
TR | 05.02.2020 | ||
BG | 05.05.2020 | ||
NO | 05.05.2020 | ||
GR | 06.05.2020 | ||
IS | 05.06.2020 | ||
PT | 28.06.2020 | ||
LU | 10.12.2020 | ||
Former [2021/47] | AT | 05.02.2020 | |
CZ | 05.02.2020 | ||
DK | 05.02.2020 | ||
EE | 05.02.2020 | ||
FI | 05.02.2020 | ||
HR | 05.02.2020 | ||
LT | 05.02.2020 | ||
LV | 05.02.2020 | ||
MC | 05.02.2020 | ||
NL | 05.02.2020 | ||
PL | 05.02.2020 | ||
RO | 05.02.2020 | ||
RS | 05.02.2020 | ||
SE | 05.02.2020 | ||
SI | 05.02.2020 | ||
SK | 05.02.2020 | ||
SM | 05.02.2020 | ||
BG | 05.05.2020 | ||
NO | 05.05.2020 | ||
GR | 06.05.2020 | ||
IS | 05.06.2020 | ||
PT | 28.06.2020 | ||
LU | 10.12.2020 | ||
Former [2021/40] | AT | 05.02.2020 | |
CZ | 05.02.2020 | ||
DK | 05.02.2020 | ||
EE | 05.02.2020 | ||
FI | 05.02.2020 | ||
HR | 05.02.2020 | ||
LT | 05.02.2020 | ||
LV | 05.02.2020 | ||
MC | 05.02.2020 | ||
NL | 05.02.2020 | ||
PL | 05.02.2020 | ||
RO | 05.02.2020 | ||
RS | 05.02.2020 | ||
SE | 05.02.2020 | ||
SI | 05.02.2020 | ||
SK | 05.02.2020 | ||
SM | 05.02.2020 | ||
BG | 05.05.2020 | ||
NO | 05.05.2020 | ||
GR | 06.05.2020 | ||
IS | 05.06.2020 | ||
PT | 28.06.2020 | ||
Former [2021/11] | AT | 05.02.2020 | |
CZ | 05.02.2020 | ||
DK | 05.02.2020 | ||
EE | 05.02.2020 | ||
FI | 05.02.2020 | ||
HR | 05.02.2020 | ||
LT | 05.02.2020 | ||
LV | 05.02.2020 | ||
NL | 05.02.2020 | ||
PL | 05.02.2020 | ||
RO | 05.02.2020 | ||
RS | 05.02.2020 | ||
SE | 05.02.2020 | ||
SI | 05.02.2020 | ||
SK | 05.02.2020 | ||
SM | 05.02.2020 | ||
BG | 05.05.2020 | ||
NO | 05.05.2020 | ||
GR | 06.05.2020 | ||
IS | 05.06.2020 | ||
PT | 28.06.2020 | ||
Former [2020/50] | CZ | 05.02.2020 | |
DK | 05.02.2020 | ||
EE | 05.02.2020 | ||
FI | 05.02.2020 | ||
HR | 05.02.2020 | ||
LT | 05.02.2020 | ||
LV | 05.02.2020 | ||
NL | 05.02.2020 | ||
RO | 05.02.2020 | ||
RS | 05.02.2020 | ||
SE | 05.02.2020 | ||
SK | 05.02.2020 | ||
SM | 05.02.2020 | ||
BG | 05.05.2020 | ||
NO | 05.05.2020 | ||
GR | 06.05.2020 | ||
IS | 05.06.2020 | ||
PT | 28.06.2020 | ||
Former [2020/49] | CZ | 05.02.2020 | |
DK | 05.02.2020 | ||
FI | 05.02.2020 | ||
HR | 05.02.2020 | ||
LT | 05.02.2020 | ||
LV | 05.02.2020 | ||
NL | 05.02.2020 | ||
RO | 05.02.2020 | ||
RS | 05.02.2020 | ||
SE | 05.02.2020 | ||
SK | 05.02.2020 | ||
SM | 05.02.2020 | ||
BG | 05.05.2020 | ||
NO | 05.05.2020 | ||
GR | 06.05.2020 | ||
IS | 05.06.2020 | ||
PT | 28.06.2020 | ||
Former [2020/48] | DK | 05.02.2020 | |
FI | 05.02.2020 | ||
HR | 05.02.2020 | ||
LT | 05.02.2020 | ||
LV | 05.02.2020 | ||
NL | 05.02.2020 | ||
RO | 05.02.2020 | ||
RS | 05.02.2020 | ||
SE | 05.02.2020 | ||
SM | 05.02.2020 | ||
BG | 05.05.2020 | ||
NO | 05.05.2020 | ||
GR | 06.05.2020 | ||
IS | 05.06.2020 | ||
PT | 28.06.2020 | ||
Former [2020/47] | DK | 05.02.2020 | |
FI | 05.02.2020 | ||
HR | 05.02.2020 | ||
LT | 05.02.2020 | ||
LV | 05.02.2020 | ||
NL | 05.02.2020 | ||
RS | 05.02.2020 | ||
SE | 05.02.2020 | ||
BG | 05.05.2020 | ||
NO | 05.05.2020 | ||
GR | 06.05.2020 | ||
IS | 05.06.2020 | ||
PT | 28.06.2020 | ||
Former [2020/45] | FI | 05.02.2020 | |
HR | 05.02.2020 | ||
LV | 05.02.2020 | ||
NL | 05.02.2020 | ||
RS | 05.02.2020 | ||
SE | 05.02.2020 | ||
BG | 05.05.2020 | ||
NO | 05.05.2020 | ||
GR | 06.05.2020 | ||
IS | 05.06.2020 | ||
PT | 28.06.2020 | ||
Former [2020/40] | FI | 05.02.2020 | |
HR | 05.02.2020 | ||
LV | 05.02.2020 | ||
RS | 05.02.2020 | ||
SE | 05.02.2020 | ||
BG | 05.05.2020 | ||
NO | 05.05.2020 | ||
GR | 06.05.2020 | ||
IS | 05.06.2020 | ||
PT | 28.06.2020 | ||
Former [2020/39] | FI | 05.02.2020 | |
HR | 05.02.2020 | ||
LV | 05.02.2020 | ||
RS | 05.02.2020 | ||
SE | 05.02.2020 | ||
BG | 05.05.2020 | ||
NO | 05.05.2020 | ||
GR | 06.05.2020 | ||
PT | 28.06.2020 | ||
Former [2020/38] | FI | 05.02.2020 | |
HR | 05.02.2020 | ||
LV | 05.02.2020 | ||
RS | 05.02.2020 | ||
SE | 05.02.2020 | ||
NO | 05.05.2020 | ||
GR | 06.05.2020 | ||
PT | 28.06.2020 | ||
Former [2020/37] | FI | 05.02.2020 | |
HR | 05.02.2020 | ||
LV | 05.02.2020 | ||
RS | 05.02.2020 | ||
SE | 05.02.2020 | ||
NO | 05.05.2020 | ||
PT | 28.06.2020 | ||
Former [2020/35] | FI | 05.02.2020 | |
NO | 05.05.2020 | Documents cited: | Search | [A]WO9915676 (UNIV SINGAPORE [SG]) [A] 1-14 * example -; claim -; sequence 4 *; | [A]EP2050820 (SEIKAGAKU KOGYO CO LTD [JP]) [A] 1-14 * the whole document *; | [A]WO2012118226 (SEIKAGAKU KOGYO CO LTD [JP], et al) [A] 1-14 * example -; claim - *; | [A] - DING JEAK LING ET AL, Chapter 9: Endotoxin Detection - from Limulus Amebocyte Lysate to Recombinant Factor C, ENDOTOXINS: STRUCTURE, FUNCTION AND RECOGNITION - SERIES : SUBCELLULAR BIOCHEMISTRY IN: SUBCELLULAR BIOCHEMISTRY : REVIEWS AND ESSAYS DEALING WITH THE FUNCTION, GENETICS, BIOGENESIS AND EVOLUTION OF SUB-CELLULAR COMPONENTS, ISSN 0096-8757 ; VOL. 53;, (20100101), ISBN 978-90-481-9077-5, XP009510157 [A] 1-14 * the whole document * DOI: http://dx.doi.org/10.1007/978-90-481-9078-2_9 | [A] - DWARAKANATH ROOPASHREE S ET AL, "Recombinant COS-1 cells express Carcinoscorpius rotundicauda factor C", BIOTECHNOLOGY LETTERS, (199704), vol. 19, no. 4, ISSN 0141-5492, pages 357 - 361, XP002787576 [A] 1-14 * page 359, column r, paragraph 2 * * page 360, column r, paragraph 1 * DOI: http://dx.doi.org/10.1023/A:1018307118879 | [T] - HIRAKU MIZUMURA ET AL, "Genetic engineering approach to develop next-generation reagents for endotoxin quantificationin Cos-1", INNATE IMMUNITY, (201702), vol. 23, no. 2, doi:10.1177/1753425916681074, pages 136 - 146, XP002787577 DOI: http://dx.doi.org/10.1177/1753425916681074 | by applicant | US5712144 | WO2008004674 | WO2012118226 | - IWANAGA S., Curr. Opin. Immunol., (19930200), vol. 5, no. 1, pages 74 - 82 | - NAKAMURA T. et al., J. Biochem., (19860300), vol. 99, no. 3, pages 847 - 57 | - ROOPASHREE S. DWARAKANATH et al., Biotechnology letters, (19970000), vol. 19, no. 4, pages 357 - 361 | - JING WANG; BOW HO; JEAK L. DING, Biotechnology letters, (20010000), vol. 23, pages 71 - 76 | - MAKOTO TAKEDA et al., J. Viol., (20050000), vol. 79, no. 22, pages 14346 - 54 | - MIYATA et al., Protein Nucleic acid Enzyme, (19860000), pages 30 - 43 | - YOSHIKI MIURA et al., J. Biochem., (19920000), vol. 112, pages 476 - 481 | - HASHIGUTI et al., "Expression of Recombinant Protein Using Cultured Human Cells -Standard Protocol by 293-type cells", PSSJ Archives, vol. 1, (20080000), page e017, URL: http://www.pssj.jp/archives/Protocol/Expression/293_01/293_01 _01.html | - TAKANORI NAKAMURA et al., Eur. J. Biochem., (19860000), vol. 154, pages 511 - 521 | - JEAK L. DING et al., Biochem. Biophys. Acta, vol. 1202, pages 149 - 156 | - JEAK L. DING et al., Biochem. Biophys. Acta, (19930000), vol. 1202, pages 149 - 156 | - JING WANG et al., J. Biol. Chem., (20020000), vol. 277, no. 39, pages 36363 - 72 | - ROBERT L. HARRISON; DONALD L. JARVIS, Methods in Molecular Biology, (20070000), vol. 338, pages 341 - 356 | Opposition | US5858706 | US6645724 | - WANG, JING et al., "Modular Arrangement and Secretion of a Multidomain Serine Protease- Evidence for involvement of proline-rich region and N-glycans in the secretion pathway", J. Biol. Chem., (20020000), vol. 277, no. 39, pages 36363 - 36372, XP055752086 DOI: http://dx.doi.org/10.1074/jbc.M202837200 | - CARLESSO, E. et al., "The rule regulating pH changes during crystalloid infusion", Intensive Care Med., (20110000), vol. 37, no. 3, doi:10.1007/s00134-010-2095-y, pages 461 - 468, XP019884376 DOI: http://dx.doi.org/10.1007/s00134-010-2095-y | - "Blood Plasma", Wikipedia, (20121114), URL: https://en.wikipedia.org/w/index.php?title=Blood_plasma&oldid=522988091, XP055752087 | - "Horseshoe Crab", Wikipedia, (20111117), URL: https://en.wikipedia.org/w/index.php?title=Horseshoe_crab&oldid=461115477, XP05575209 | - DING, JEAK L. et al., "A new era in pyrogen testing", TRENDS in Biotech., (20010000), vol. 19, no. 8, doi:10.1016/S0167-7799(01)01694-8, pages 277 - 281, XP004254274 DOI: http://dx.doi.org/10.1016/S0167-7799(01)01694-8 | - HARADA-SUZUKI, T. et al., "Further Studies on the Chromogenic Substrate Assay Method for Bacterial Endotoxins Using Horseshoe Crab (Tachypleus tridentatus) Hemocyte Lysate", J. Biochem., (19820000), vol. 92, no. 3, pages 793 - 800, XP055752099 DOI: http://dx.doi.org/10.1093/oxfordjournals.jbchem.a133991 | - TOMIYA, N. et al., "Comparing N-glycan processing in mammalian cell lines to native and engineered lepidopteran insect cell lines", Glycoconjugate Journal, (20040000), vol. 21, doi:10.1023/B:GLYC.0000046275.28315.87, pages 343 - 360, XP019207025 DOI: http://dx.doi.org/10.1023/B:GLYC.0000046275.28315.87 | - Joanne E. Nettleship, "Chapter 3 - Structural Biology of Glycoproteins", Glycosylation, (2012), pages 41 - 62, XP055752108 | - HOSSLER, P . et al., "Optimal and consistent protein glycosylation in mammalian cell culture", Gycobiol, vol. 19, no. 9, doi:10.1093/glycob/cwp079, pages 936 - 949, XP055112498 DOI: http://dx.doi.org/10.1093/glycob/cwp079 | - THOMAS, P. et al., "HEK293 cell line: A vehicle for the expression of recombinant proteins", J. Pharmacol. And Toxicol. Methods, (20050000), vol. 51, doi:10.1016/j.vascn.2004.08.014, pages 187 - 200, XP004873792 DOI: http://dx.doi.org/10.1016/j.vascn.2004.08.014 | - KOSHIBA, T. et al., "A Structural Perspective on the Interaction between Lipopolysaccharide and Factor C, a Receptor Involved in Recognition of Gram-negative Bacteria", J. Biol. Chem, (20070000), vol. 282, no. 6, doi:10.1074/jbc.M609198200, pages 3962 - 3967, XP055530584 DOI: http://dx.doi.org/10.1074/jbc.M609198200 | - KINGSTON, R. E. et al., "Amplification Using CHO Cell Expression Vectors", Current Protocols in Molecular Biology, (19930000), vol. Unit 16.23, no. suppl. 60, pages 16.23.1 - 16.23.13, XP055752113 DOI: http://dx.doi.org/10.1002/0471142727.mb1623s60 | - ALBERTS et al., ESSENTIAL CELL BIOLOGY, 2nd ed., New York and London, (20040000), page 209, XP055752117 |